<DOC>
	<DOCNO>NCT00732719</DOCNO>
	<brief_summary>To evaluate safety prototype Compression Device subject Oedema</brief_summary>
	<brief_title>Compression Device Safety Study Edema</brief_title>
	<detailed_description />
	<mesh_term>Edema</mesh_term>
	<criteria>Subjects age 18 80 , willing able provide write informed consent , able wear device follow requirement protocol Subjects ankle brachial pressure index ( ABPI ) least 0.8 . Subjects suffer chronic oedema ( i.e . CEAP classification C3 , C4 C5 1 . ) Subjects Chronic Venous Insufficiency ( CVI ) , present 6 week longer reflux &gt; 0.5 sec one major venous segment , superficial deep ( CEAP classification : C3C5 1. ; Ep , ; As , ; Pr ) . Subjects history skin sensitivity component study product . Subjects previously enter study Subjects history Deep Vein Thrombosis ( DVT ) within last 6 month Subjects active leg ulcer ( i.e . CEAP classification C6 1 ) . Subjects active cardiac disease significant history cardiac disease ( include history myocardial infarction , heart failure , valvular disease , arrhythmia pacemaker previously pacemaker ) . Subjects initiate treatment change dose within past month pharmaceutical agent reduce clot e.g . aspirin ( except lowdose aspirin ) , antiplatelets , anticoagulant coumarin . Subjects currently take pharmaceutical agent modify amount leg oedema ( e.g. , diuretic , dihydropyridine calcium channel blocker , phlebotonic drug , fluctuate dos systemic steroid ) take agent within last 10 day . Subjects pregnant Subjects worn compression therapy last 48 hour</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>